A randomized Southwest Oncology Group study comparing dexamethasone (D) to lenalidomide + dexamethasone (LD) as treatment of newly-diagnosed multiple myeloma (NDMM): Impact of cytogenetic abnormalities on efficacy of LD, and updated overall study results
Year: 2008
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: J. A. Zonder, J. J. Crowley, V. Bolejack, M. A. Hussein, D. F. Moore, B. F. Whittenberger, M. H. Abidi, B. G. Durie, B. Barlogie
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W52949034